The global Drug Eluting Coronary Stent market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
A Drug-Eluting Coronary Stent (DES) is a medical device used in interventional cardiology to treat coronary artery disease. It is a tiny, expandable mesh tube made of metal (usually stainless steel or cobalt-chromium) that is coated with a special medication (drug) designed to prevent the renarrowing of the coronary artery after it has been treated with balloon angioplasty and stent placement.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Drug Eluting Coronary Stent manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Coronary Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Coronary Stent. This report contains market size and forecasts of Drug Eluting Coronary Stent in global, including the following market information:
Global Drug Eluting Coronary Stent market revenue, 2020-2025, 2026-2032, ($ millions)
Global Drug Eluting Coronary Stent market sales, 2020-2025, 2026-2032, (K Units)
Global top five Drug Eluting Coronary Stent companies in 2024 (%)
Total Market by Segment:
Global Drug Eluting Coronary Stent market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Drug Eluting Coronary Stent market segment percentages, by Type, 2024 (%)
Sirolimus
Everolimus
Others
Global Drug Eluting Coronary Stent market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Drug Eluting Coronary Stent market segment percentages, by Application, 2024 (%)
Angina Pectoris
Myocardial Infarction
Global Drug Eluting Coronary Stent market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Drug Eluting Coronary Stent market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Coronary Stent revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Drug Eluting Coronary Stent revenues share in global market, 2024 (%)
Key companies Drug Eluting Coronary Stent sales in global market, 2020-2025 (estimated), (K Units)
Key companies Drug Eluting Coronary Stent sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Medtronic
Abbott
Sahajanand Laser Technology Limited (SLTL Group)
Meril Life Sciences
Concept Medical
BIOTRONIK
Relisys
Lepu Medical Technology(Beijing)
Micell Technologies
Terumo Corporation
Biosensors International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Eluting Coronary Stent, market overview.
Chapter 2: Global Drug Eluting Coronary Stent market size in revenue and volume.
Chapter 3: Detailed analysis of Drug Eluting Coronary Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Eluting Coronary Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug Eluting Coronary Stent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drug Eluting Coronary Stent Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Drug Eluting Coronary Stent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Eluting Coronary Stent Overall Market Size
2.1 Global Drug Eluting Coronary Stent Market Size: 2024 VS 2032
2.2 Global Drug Eluting Coronary Stent Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Drug Eluting Coronary Stent Sales: 2020-2032
3 Company Landscape
3.1 Top Drug Eluting Coronary Stent Players in Global Market
3.2 Top Global Drug Eluting Coronary Stent Companies Ranked by Revenue
3.3 Global Drug Eluting Coronary Stent Revenue by Companies
3.4 Global Drug Eluting Coronary Stent Sales by Companies
3.5 Global Drug Eluting Coronary Stent Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Drug Eluting Coronary Stent Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Drug Eluting Coronary Stent Product Type
3.8 Tier 1, Tier 2, and Tier 3 Drug Eluting Coronary Stent Players in Global Market
3.8.1 List of Global Tier 1 Drug Eluting Coronary Stent Companies
3.8.2 List of Global Tier 2 and Tier 3 Drug Eluting Coronary Stent Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Drug Eluting Coronary Stent Market Size Markets, 2024 & 2032
4.1.2 Sirolimus
4.1.3 Everolimus
4.1.4 Others
4.2 Segment by Type - Global Drug Eluting Coronary Stent Revenue & Forecasts
4.2.1 Segment by Type - Global Drug Eluting Coronary Stent Revenue, 2020-2025
4.2.2 Segment by Type - Global Drug Eluting Coronary Stent Revenue, 2026-2032
4.2.3 Segment by Type - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Drug Eluting Coronary Stent Sales & Forecasts
4.3.1 Segment by Type - Global Drug Eluting Coronary Stent Sales, 2020-2025
4.3.2 Segment by Type - Global Drug Eluting Coronary Stent Sales, 2026-2032
4.3.3 Segment by Type - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
4.4 Segment by Type - Global Drug Eluting Coronary Stent Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Drug Eluting Coronary Stent Market Size, 2024 & 2032
5.1.2 Angina Pectoris
5.1.3 Myocardial Infarction
5.2 Segment by Application - Global Drug Eluting Coronary Stent Revenue & Forecasts
5.2.1 Segment by Application - Global Drug Eluting Coronary Stent Revenue, 2020-2025
5.2.2 Segment by Application - Global Drug Eluting Coronary Stent Revenue, 2026-2032
5.2.3 Segment by Application - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Drug Eluting Coronary Stent Sales & Forecasts
5.3.1 Segment by Application - Global Drug Eluting Coronary Stent Sales, 2020-2025
5.3.2 Segment by Application - Global Drug Eluting Coronary Stent Sales, 2026-2032
5.3.3 Segment by Application - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
5.4 Segment by Application - Global Drug Eluting Coronary Stent Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Drug Eluting Coronary Stent Market Size, 2024 & 2032
6.2 By Region - Global Drug Eluting Coronary Stent Revenue & Forecasts
6.2.1 By Region - Global Drug Eluting Coronary Stent Revenue, 2020-2025
6.2.2 By Region - Global Drug Eluting Coronary Stent Revenue, 2026-2032
6.2.3 By Region - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
6.3 By Region - Global Drug Eluting Coronary Stent Sales & Forecasts
6.3.1 By Region - Global Drug Eluting Coronary Stent Sales, 2020-2025
6.3.2 By Region - Global Drug Eluting Coronary Stent Sales, 2026-2032
6.3.3 By Region - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Drug Eluting Coronary Stent Revenue, 2020-2032
6.4.2 By Country - North America Drug Eluting Coronary Stent Sales, 2020-2032
6.4.3 United States Drug Eluting Coronary Stent Market Size, 2020-2032
6.4.4 Canada Drug Eluting Coronary Stent Market Size, 2020-2032
6.4.5 Mexico Drug Eluting Coronary Stent Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Drug Eluting Coronary Stent Revenue, 2020-2032
6.5.2 By Country - Europe Drug Eluting Coronary Stent Sales, 2020-2032
6.5.3 Germany Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.4 France Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.5 U.K. Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.6 Italy Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.7 Russia Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.8 Nordic Countries Drug Eluting Coronary Stent Market Size, 2020-2032
6.5.9 Benelux Drug Eluting Coronary Stent Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Drug Eluting Coronary Stent Revenue, 2020-2032
6.6.2 By Region - Asia Drug Eluting Coronary Stent Sales, 2020-2032
6.6.3 China Drug Eluting Coronary Stent Market Size, 2020-2032
6.6.4 Japan Drug Eluting Coronary Stent Market Size, 2020-2032
6.6.5 South Korea Drug Eluting Coronary Stent Market Size, 2020-2032
6.6.6 Southeast Asia Drug Eluting Coronary Stent Market Size, 2020-2032
6.6.7 India Drug Eluting Coronary Stent Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Drug Eluting Coronary Stent Revenue, 2020-2032
6.7.2 By Country - South America Drug Eluting Coronary Stent Sales, 2020-2032
6.7.3 Brazil Drug Eluting Coronary Stent Market Size, 2020-2032
6.7.4 Argentina Drug Eluting Coronary Stent Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drug Eluting Coronary Stent Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Drug Eluting Coronary Stent Sales, 2020-2032
6.8.3 Turkey Drug Eluting Coronary Stent Market Size, 2020-2032
6.8.4 Israel Drug Eluting Coronary Stent Market Size, 2020-2032
6.8.5 Saudi Arabia Drug Eluting Coronary Stent Market Size, 2020-2032
6.8.6 UAE Drug Eluting Coronary Stent Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Summary
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Drug Eluting Coronary Stent Major Product Offerings
7.1.4 Boston Scientific Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.1.5 Boston Scientific Key News & Latest Developments
7.2 Medtronic
7.2.1 Medtronic Company Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Drug Eluting Coronary Stent Major Product Offerings
7.2.4 Medtronic Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.2.5 Medtronic Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Drug Eluting Coronary Stent Major Product Offerings
7.3.4 Abbott Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.3.5 Abbott Key News & Latest Developments
7.4 Sahajanand Laser Technology Limited (SLTL Group)
7.4.1 Sahajanand Laser Technology Limited (SLTL Group) Company Summary
7.4.2 Sahajanand Laser Technology Limited (SLTL Group) Business Overview
7.4.3 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Major Product Offerings
7.4.4 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.4.5 Sahajanand Laser Technology Limited (SLTL Group) Key News & Latest Developments
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Company Summary
7.5.2 Meril Life Sciences Business Overview
7.5.3 Meril Life Sciences Drug Eluting Coronary Stent Major Product Offerings
7.5.4 Meril Life Sciences Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.5.5 Meril Life Sciences Key News & Latest Developments
7.6 Concept Medical
7.6.1 Concept Medical Company Summary
7.6.2 Concept Medical Business Overview
7.6.3 Concept Medical Drug Eluting Coronary Stent Major Product Offerings
7.6.4 Concept Medical Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.6.5 Concept Medical Key News & Latest Developments
7.7 BIOTRONIK
7.7.1 BIOTRONIK Company Summary
7.7.2 BIOTRONIK Business Overview
7.7.3 BIOTRONIK Drug Eluting Coronary Stent Major Product Offerings
7.7.4 BIOTRONIK Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.7.5 BIOTRONIK Key News & Latest Developments
7.8 Relisys
7.8.1 Relisys Company Summary
7.8.2 Relisys Business Overview
7.8.3 Relisys Drug Eluting Coronary Stent Major Product Offerings
7.8.4 Relisys Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.8.5 Relisys Key News & Latest Developments
7.9 Lepu Medical Technology(Beijing)
7.9.1 Lepu Medical Technology(Beijing) Company Summary
7.9.2 Lepu Medical Technology(Beijing) Business Overview
7.9.3 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Major Product Offerings
7.9.4 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.9.5 Lepu Medical Technology(Beijing) Key News & Latest Developments
7.10 Micell Technologies
7.10.1 Micell Technologies Company Summary
7.10.2 Micell Technologies Business Overview
7.10.3 Micell Technologies Drug Eluting Coronary Stent Major Product Offerings
7.10.4 Micell Technologies Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.10.5 Micell Technologies Key News & Latest Developments
7.11 Terumo Corporation
7.11.1 Terumo Corporation Company Summary
7.11.2 Terumo Corporation Business Overview
7.11.3 Terumo Corporation Drug Eluting Coronary Stent Major Product Offerings
7.11.4 Terumo Corporation Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.11.5 Terumo Corporation Key News & Latest Developments
7.12 Biosensors International
7.12.1 Biosensors International Company Summary
7.12.2 Biosensors International Business Overview
7.12.3 Biosensors International Drug Eluting Coronary Stent Major Product Offerings
7.12.4 Biosensors International Drug Eluting Coronary Stent Sales and Revenue in Global (2020-2025)
7.12.5 Biosensors International Key News & Latest Developments
8 Global Drug Eluting Coronary Stent Production Capacity, Analysis
8.1 Global Drug Eluting Coronary Stent Production Capacity, 2020-2032
8.2 Drug Eluting Coronary Stent Production Capacity of Key Manufacturers in Global Market
8.3 Global Drug Eluting Coronary Stent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drug Eluting Coronary Stent Supply Chain Analysis
10.1 Drug Eluting Coronary Stent Industry Value Chain
10.2 Drug Eluting Coronary Stent Upstream Market
10.3 Drug Eluting Coronary Stent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drug Eluting Coronary Stent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Drug Eluting Coronary Stent in Global Market
Table 2. Top Drug Eluting Coronary Stent Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Drug Eluting Coronary Stent Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Drug Eluting Coronary Stent Revenue Share by Companies, 2020-2025
Table 5. Global Drug Eluting Coronary Stent Sales by Companies, (K Units), 2020-2025
Table 6. Global Drug Eluting Coronary Stent Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Drug Eluting Coronary Stent Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Drug Eluting Coronary Stent Product Type
Table 9. List of Global Tier 1 Drug Eluting Coronary Stent Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Eluting Coronary Stent Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Drug Eluting Coronary Stent Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Drug Eluting Coronary Stent Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Drug Eluting Coronary Stent Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Drug Eluting Coronary Stent Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 21. By Region � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 25. By Region - Global Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 26. By Country - North America Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 29. By Country - North America Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 30. By Country - Europe Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 33. By Country - Europe Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 34. By Region - Asia Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 37. By Region - Asia Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 38. By Country - South America Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 41. By Country - South America Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Drug Eluting Coronary Stent Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Drug Eluting Coronary Stent Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Drug Eluting Coronary Stent Sales, (K Units), 2026-2032
Table 46. Boston Scientific Company Summary
Table 47. Boston Scientific Drug Eluting Coronary Stent Product Offerings
Table 48. Boston Scientific Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Boston Scientific Key News & Latest Developments
Table 50. Medtronic Company Summary
Table 51. Medtronic Drug Eluting Coronary Stent Product Offerings
Table 52. Medtronic Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Medtronic Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Drug Eluting Coronary Stent Product Offerings
Table 56. Abbott Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Abbott Key News & Latest Developments
Table 58. Sahajanand Laser Technology Limited (SLTL Group) Company Summary
Table 59. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product Offerings
Table 60. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Sahajanand Laser Technology Limited (SLTL Group) Key News & Latest Developments
Table 62. Meril Life Sciences Company Summary
Table 63. Meril Life Sciences Drug Eluting Coronary Stent Product Offerings
Table 64. Meril Life Sciences Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Meril Life Sciences Key News & Latest Developments
Table 66. Concept Medical Company Summary
Table 67. Concept Medical Drug Eluting Coronary Stent Product Offerings
Table 68. Concept Medical Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Concept Medical Key News & Latest Developments
Table 70. BIOTRONIK Company Summary
Table 71. BIOTRONIK Drug Eluting Coronary Stent Product Offerings
Table 72. BIOTRONIK Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. BIOTRONIK Key News & Latest Developments
Table 74. Relisys Company Summary
Table 75. Relisys Drug Eluting Coronary Stent Product Offerings
Table 76. Relisys Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Relisys Key News & Latest Developments
Table 78. Lepu Medical Technology(Beijing) Company Summary
Table 79. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product Offerings
Table 80. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Lepu Medical Technology(Beijing) Key News & Latest Developments
Table 82. Micell Technologies Company Summary
Table 83. Micell Technologies Drug Eluting Coronary Stent Product Offerings
Table 84. Micell Technologies Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Micell Technologies Key News & Latest Developments
Table 86. Terumo Corporation Company Summary
Table 87. Terumo Corporation Drug Eluting Coronary Stent Product Offerings
Table 88. Terumo Corporation Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Terumo Corporation Key News & Latest Developments
Table 90. Biosensors International Company Summary
Table 91. Biosensors International Drug Eluting Coronary Stent Product Offerings
Table 92. Biosensors International Drug Eluting Coronary Stent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Biosensors International Key News & Latest Developments
Table 94. Drug Eluting Coronary Stent Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 95. Global Drug Eluting Coronary Stent Capacity Market Share of Key Manufacturers, 2023-2025
Table 96. Global Drug Eluting Coronary Stent Production by Region, 2020-2025 (K Units)
Table 97. Global Drug Eluting Coronary Stent Production by Region, 2026-2032 (K Units)
Table 98. Drug Eluting Coronary Stent Market Opportunities & Trends in Global Market
Table 99. Drug Eluting Coronary Stent Market Drivers in Global Market
Table 100. Drug Eluting Coronary Stent Market Restraints in Global Market
Table 101. Drug Eluting Coronary Stent Raw Materials
Table 102. Drug Eluting Coronary Stent Raw Materials Suppliers in Global Market
Table 103. Typical Drug Eluting Coronary Stent Downstream
Table 104. Drug Eluting Coronary Stent Downstream Clients in Global Market
Table 105. Drug Eluting Coronary Stent Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drug Eluting Coronary Stent Product Picture
Figure 2. Drug Eluting Coronary Stent Segment by Type in 2024
Figure 3. Drug Eluting Coronary Stent Segment by Application in 2024
Figure 4. Global Drug Eluting Coronary Stent Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Drug Eluting Coronary Stent Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Drug Eluting Coronary Stent Revenue: 2020-2032 (US$, Mn)
Figure 8. Drug Eluting Coronary Stent Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Drug Eluting Coronary Stent Revenue in 2024
Figure 10. Segment by Type � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Drug Eluting Coronary Stent Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Drug Eluting Coronary Stent Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Drug Eluting Coronary Stent Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Drug Eluting Coronary Stent Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 21. By Region - Global Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 22. By Country - North America Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 23. By Country - North America Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 24. United States Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 29. Germany Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 30. France Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Drug Eluting Coronary Stent Sales Market Share, 2020-2032
Figure 38. China Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 42. India Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Drug Eluting Coronary Stent Revenue Market Share, 2020-2032
Figure 44. By Country - South America Drug Eluting Coronary Stent Sales, Market Share, 2020-2032
Figure 45. Brazil Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Drug Eluting Coronary Stent Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Drug Eluting Coronary Stent Sales, Market Share, 2020-2032
Figure 49. Turkey Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Drug Eluting Coronary Stent Revenue, (US$, Mn), 2020-2032
Figure 53. Global Drug Eluting Coronary Stent Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Drug Eluting Coronary Stent by Region, 2024 VS 2032
Figure 55. Drug Eluting Coronary Stent Industry Value Chain
Figure 56. Marketing Channels
